IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

ROMEO, SERGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.244
NA - Nord America 3.679
AS - Asia 2.369
SA - Sud America 64
AF - Africa 26
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 4
Totale 11.412
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.609
GB - Regno Unito 1.993
CN - Cina 1.063
IT - Italia 908
DE - Germania 682
SE - Svezia 527
SG - Singapore 426
RU - Federazione Russa 254
IN - India 199
TR - Turchia 187
UA - Ucraina 183
KR - Corea 161
IE - Irlanda 136
FR - Francia 124
FI - Finlandia 95
JP - Giappone 95
DK - Danimarca 90
HK - Hong Kong 85
EU - Europa 79
NL - Olanda 77
CA - Canada 59
CO - Colombia 46
BE - Belgio 41
VN - Vietnam 37
ID - Indonesia 34
GR - Grecia 28
IR - Iran 26
PL - Polonia 22
PH - Filippine 20
CH - Svizzera 14
NZ - Nuova Zelanda 14
AT - Austria 12
AU - Australia 12
ES - Italia 12
BR - Brasile 9
PT - Portogallo 9
RO - Romania 9
MX - Messico 8
CZ - Repubblica Ceca 7
SI - Slovenia 7
ZA - Sudafrica 7
CL - Cile 5
LB - Libano 5
TW - Taiwan 5
EG - Egitto 4
IQ - Iraq 4
MY - Malesia 4
NG - Nigeria 4
SC - Seychelles 4
TH - Thailandia 4
MA - Marocco 3
PK - Pakistan 3
UZ - Uzbekistan 3
EC - Ecuador 2
HR - Croazia 2
IL - Israele 2
KE - Kenya 2
LV - Lettonia 2
PE - Perù 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BY - Bielorussia 1
GE - Georgia 1
HU - Ungheria 1
IM - Isola di Man 1
IS - Islanda 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
MD - Moldavia 1
PA - Panama 1
RS - Serbia 1
SD - Sudan 1
SK - Slovacchia (Repubblica Slovacca) 1
UG - Uganda 1
Totale 11.487
Salva come PNG Salva come JPEG
Città #
Southend 1.847
Milan 427
Chandler 421
Singapore 278
Seattle 273
Ann Arbor 266
Beijing 200
Princeton 195
Dearborn 192
Wilmington 178
Ashburn 177
Fairfield 145
Frankfurt am Main 136
Dublin 133
Jacksonville 133
Woodbridge 125
Mountain View 115
Nanjing 111
Redmond 88
Munich 77
Houston 75
Boardman 71
Jinan 71
Hong Kong 66
Des Moines 61
Grafing 60
Sakarya 60
Bengaluru 59
Hanover 58
Shenyang 58
Serra 56
Somerville 56
Cambridge 55
Phoenix 54
Shanghai 51
Andover 48
Redwood City 48
Bogotá 46
Istanbul 42
Toronto 41
Pisa 39
Brussels 38
Changsha 36
Guangzhou 36
Kent 35
Medford 33
Nanchang 33
Roxbury 33
Hangzhou 31
Santa Clara 31
Berlin 29
Athens 28
Torino 28
Ningbo 26
Eitensheim 24
Tianjin 23
Hebei 22
Jiaxing 22
Zhengzhou 20
Fremont 19
Monza 19
Haikou 18
Madison 18
Taizhou 18
Fuzhou 17
Helsinki 16
Jakarta 16
New York 16
Hamburg 15
Lanzhou 15
Los Angeles 15
Rome 15
Warsaw 15
Bühl 14
Piscataway 14
San Diego 14
Seoul 14
Tabriz 14
Falls Church 13
Delhi 12
Wuhan 12
Auckland 11
Bitonto 11
Hefei 11
Central District 10
Kunming 10
Quanzhou 10
Mumbai 9
Vienna 9
Auburn Hills 8
Tokyo 8
Chengdu 7
Ottawa 7
Cisterna di Latina 6
Lisbon 6
Turin 6
Washington 6
Xiamen 6
Chicago 5
Costa Mesa 5
Totale 7.710
Salva come PNG Salva come JPEG
Nome #
Theranostic nanocages for imaging and photothermal therapy of prostate cancer cells by active targeting of neuropeptide-Y receptor 296
Synthesis of new dithiolethione and methanethiosulfonate systems endowed with pharmaceutical interest 284
How selection was made for a new antimalarial drug candidate : from AM1 to MG3, two novel series of 4-aminoquinoline derivatives 257
Selective and active targeting of neuropeptide Y receptors in experimental oncology: use of gold nanocages conjugated to short peptides 237
High antiplasmodial activity of novel plasmepsins I and II inhibitors 225
Picomolar Inhibition of Plasmepsin V, an Essential Malaria Protease, Achieved Exploiting the Prime Region 193
Novel biotinylated bile acid amphiphiles: micellar aggregates formation and interaction with hepatocytes 190
Antiplasmodial activity of Punica granatum L. fruit rind 187
Theranostic nanocages for imaging and photothermal therapy of prostate cancer cells by active targeting of neuropeptide-Y receptor 187
PLASMEPSIN II INHIBITION AND ANTIPLASMODIAL ACTIVITY OF PRIMAQUINE-STATINE “DOUBLE-DRUGS” 186
Old and new targets for innovative antimalarial compounds : the different strategies of the Italian Malaria Network 185
Synthesis of gallocatechin-3-gallate analogues 180
In Vivo and In Vitro Activities and ADME-Tox Profile of a Quinolizidine-Modified 4-Aminoquinoline : A Potent Anti-P. falciparum and Anti-P. vivax Blood-Stage Antimalarial 173
Discovery of oxybisbenzoylamides as a new class of antimalarial agents 172
4-Aminoquinoline-statine double drugs 171
Discovery and pharmacophore mapping of a new low nanomolar inhibitor of P. falciparum growth 166
A structure-activity study for the inhibition of metalloproteinase-9 activity and gene expression by analogues of gallocatechin-3-gallate 164
POMEGRANATE ELLAGITANNINS ANTAGONIZE IN VITRO THE INFLAMMATORY RESPONSE INVOLVED IN MALARIA 163
Gold nanocages for imaging and therapy of prostate cancer cells 163
A structure-activity study for the inhibition of metalloprotease-9 activity and gene expression by analogues of gallocatechin-3-gallate 162
Antiparasitic activities and toxicities of individual enantiomers of 7-chloro-N-[[(9a)-octahydro-2H-quinolizin-1-yl]methyl]-4-quinolinamine 161
High resolution mass spectrometry based approach to investigate RAGE-ligand interactions 154
Ability of quinolizidinyl- and quinolizidinylalkyl-derivatives of 4-aminoquinoline to overcome chloroquine resistance 153
In vitro and in vivo evaluation and early transitioning studies of novel quinolizidinyl- and quinolizidinylalkyl- derivatives of 4-aminoquinoline with potent antimalarial activity 148
Production of active recombinant PfPM1 and PbPM4 and inhibition analysis with a series of statine-based compounds 145
Antiplasmodial activity of Punica granatum L. fruit rind 144
In vitro characterization, structural optimization and in silico pharmacophore modeling of a new antiplasmodial chemotype 144
Antiparasitic activity and ADME-tox profile of new 4-aminoquinoline derivatives 142
SYNTHESIS OF ANALOGUES OF GALLOCATECHIN-3-GALLATE AS INHIBITORS OF METALLOPROTEINASE-9 ACTIVITY AND GENE EXPRESSION 141
Plasmepsin II inhibition and antiplasmodial activity of Primaquine-Statine 'double-drugs' 141
Parallel synthesis and antileishmanial activity of ether-linked phospholipids 140
Antimalarial activity of novel pyrrolizidinyl derivatives of 4-aminoquinolines 139
Ellagitannins of the fruit rind of pomegranate (Punica granatutm) antagonize in vitro the host inflammatory response mechanisms involved in the onset of malaria 139
4-Aminoquinoline quinolizidinyl- and quinolizidinylalkyl-derivatives with antimalarial activity 139
A new high resolution mass spectrometry application for the comprehensive analysis of the ligand-binding properties of rage 138
[4-(2H-1,2,3-benzotriazol-2-yl)phenoxy]alkanoic acids as agonists of peroxisome proliferator-activated receptors (PPARs) 137
Novel inhibitors of Plasmepsins, a family of haemoglobin proteases of P. Falciparum 137
Identification and screeening of natural and synthetic products with significant antimalarial activity in vitro 135
Design, synthesis and docking studies of hydroxyethylamine and hydroxyethyl-sulfide bace-1 inhibitors 135
INHIBITION OF BACE-1 BY HYDROXYETHYLAMINE AND HYDROXYETHYLSULFIDE ISOSTERIC REPLACEMENTS 132
Antiplasmodial activities of 4-aminoquinoline–statine compounds 132
Amino acid derived epoxide ring opening tinder microwave irradiation 130
Inhibition of BACE-1 by hydroxyethylsulfide, hydroxyethylamine and hydroxyethylurea isosteric replacements 129
Antiparasitic activity and ADME-Tox profile of new 4-aminoquinoline derivatives 128
Targeting the PM4 orthologs of Plasmodium sp 127
Design, synthesis and docking studies of hydroxyethylamine and hydroxyethylsulfide BACE-1 inhibitors 127
“Blind” targeting in action : from phage display to breast cancer cell targeting with peptide-gold nanoconjugates 127
Nitric oxide releasing hyaluronic esters 127
Design and synthesis of protein–protein interaction mimics as plasmodium falciparum cysteine protease, falcipain-2 inhibitors 124
Novel amodiaquine congeners as potent antimalarial agents 121
Atovaquone-statine "Double-Drugs" with high antiplasmodial activity 121
Structural optimization, in vitro characterization and in silico pharmacophore modeling of a new antiplasmodial chemotype 121
Targeting the plasmepsin 4 orthologs of Plasmodium sp with "Double Drug" inhibitors 120
A structure-activity study for the inhibition of metalloprotease-9 activity and gene expression by analogues of gallocatechin-3-gallate 118
DESIGN AND SYNTHESIS OF PROTEIN-PROTEIN INTERACTION MIMICS AS INHIBITORS OF PLASMODIUM FALCIPARUM CYSTEINE PROTEASE FALCIPAIN-2 117
Chemical proteomics approach for target identification of a new antimalarials 117
Listening to nature's hints : exploiting a natural product scaffold to simplify a complex chemical structure 116
STUDIES FOR A DIASTEREOSELECTIVE SYNTHESIS OF THE TETRACYCLIC DITERPENIC DIOL STEMARIN - AN IMPROVED PROCEDURE FOR THE SYNTHESIS OF 8(9)-PODOCARPEN-14-ONES - THE TOTAL SYNTHESIS OF 18-BENZYLOXY-8(9)-PODOCARPEN-14-ONE AND RELATED STUDIES 114
Synthesis and comparison of antiplasmodial activity of (+), (-) and racemic 7-chloro-4-(N-lupinyl)aminoquinoline 114
A chemical proteomic approach in antimalarial drugs discovery 113
Inhibition of plasmepsin II and IV and antiplasmodial activity of primaquine-statine double drugs 112
A chemical proteomic approach in antimarial drugs discovery 112
Perfluorinated probes for non-covalent protein recognition and isolation 112
Synthesis of a potent antimalarial agent through natural products conjugation 111
Potente attività antimalarica di chinolizidinilalchil-derivati delle 4ammino-chinoline 110
Scale-up synthesis of MG3, a pyrrolizidinyl 4-aminoquinoline derivative, as novel antimalarial drug candidate 110
Nitric oxide donating carnosine compuunds 109
Insights on the mechanism of action of novel quinolizidinyl-and quinolizidinylalkyl-derivatives with antimalarial activity 106
Alcohols immobilization onto 2-chlorotritylchloridenext term resin under microwave irradiation 104
Inhibition of Plasmepsins II and IV and Antiplasmodial Activity of Primaquine–Statine Double Drugs 103
Synthesis and antimycobacterial activity of (+)-usnic acid conjugates 103
Novel quinolizidinyl and quinolizidinyl-alkyl derivatives of 4-aminoquinolines with potent antimalarial activity 100
Bovine hemoglobin cross-linked through the beta chains - Functional and structural aspects 99
The antimalarial activity of primaquine-statine "double drugs" correlates with the inhibition of plasmepsin II activity 98
STUDIES FOR A DIASTEREOSELECTIVE SYNTHESIS OF THE TETRACYCLIC DITERPENIC DIOL STEMARIN - A MODEL STUDY FOR A NEW PREPARATION OF THE KEY INTERMEDIATE AND THE SYNTHESIS OF (+)-18-DEOXYSTEMARIN 97
Design and synthesis of protein-protein interaction mimics as inhibitors of plasmodium cysteine protease falcipain-2 95
Relationships between conformational behaviour and binding affinity towards beta1 and beta2 adrenoceptors of some chiral phenoxypropanolamines with bulky N-substituents 93
Solid phase synthesis of rage ligands 88
UNPRECEDENTED OUTCOME OF THE ALLENE PHOTOADDITION TO A FUSED ALPHA,BETA-UNSATURATED KETONE 87
DIASTEREOSELECTIVE EPOXIDATION OF DIPEPTIDE OLEFINS 83
Direct interaction of natural and synthetic catechins with Signal Transducer Activator of Transcription-1 affects both its phosphorylation and activity 83
Plasmepsin V, a new promising target for antimalarial drug discovery 82
Synthetic peptides derived from the C-terminal 6kDa region of Plasmodium falciparum SERA5 inhibit the enzyme activity and malaria parasite development 78
Identification of a new class of potent bace-1 inhibitors through scaffold hopping 78
γ-HYDROXY LACTONE BASED PPARγ NON-AGONISTS AS SAFE AND INNOVATIVE ANTI-DIABETIC AGENTS 77
Preclinical characterization of MG3, a new 4-aminoquinoline derivative with potent antimalarial activity 76
STEREOSELECTIVE SYNTHESIS OF PROTECTED AMINO ALKYL EPOXIDES 74
Nitric oxide donating carnosine compuunds 74
γ-hidroxy-lactone derivatives as ppar-γ non-agonists blocking cdk5-mediated phosporylation for a safer anti-diabetic treatment 68
From DC18 to MR07: A Metabolically Stable 4,4′‐Oxybisbenzoyl Amide as a Low‐Nanomolar Growth Inhibitor of P. falciparum 64
Favorable Preclinical Pharmacological Profile of a Novel Antimalarial Pyrrolizidinylmethyl Derivative of 4-amino-7-chloroquinoline with Potent In Vitro and In Vivo Activities 59
null 56
A chemical proteomic approach in antimalarial drugs discovery 45
γ-HYDROXY LACTONE BASED PPARγ NON-AGONISTS AS SAFE AND INNOVATIVE ANTI-DIABETIC AGENTS. 25
Totale 12.199
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.326
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.326
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.399 0 0 0 0 118 195 245 78 310 275 103 75
2020/20211.315 44 114 94 21 116 90 84 80 173 115 297 87
2021/20221.351 198 111 39 101 71 62 155 57 125 89 94 249
2022/20231.531 210 155 136 147 164 280 25 137 168 16 47 46
2023/20241.198 42 77 112 117 291 75 88 57 43 82 93 121
2024/2025693 91 201 54 227 120 0 0 0 0 0 0 0
Totale 12.199